Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide insight on when it is appropriate to switch from one #biologic to another for a patient with #psoriasis in this #DermView episode.
ow.ly/CnJw50L9bcf
1
Search
Just a visual check but we are still a long ways from yield, but two on the right: F/I, Innoculant, plus #biologic (Heads up) left two are naked beans. Let me know your thoughts? AG29XF2 @Asgrow_DEKALB #scout22
For the first time, @ACSCAN report "The Costs of Cancer" includes savings f/ #biosimilars. A #breastcancer patient saw nearly 30% savings by using a biosimilar vs. brand-name #biologic. Over 10 yrs, generics saved patients w/ cancer $87.8B: accessiblemeds.org/resources/blog… @BiosimsCouncil
1
2
#Biologic combo 4 refractory #IBD @LukaszKwapisz @AGA_CGH
US Retro N15 CD14 UC 1 f/u 24m
8 aTNF+VDZ 2 aTNF+UST 5 UST+VDZ
73% symptom improvement
67% reduction of steroid use
44% endo/radio improvement
27% infections
1 pt dc VDZ due to arthralgias
cghjournal.org/article/S1542-…
2
4
10
@gene breaks down just how hard developing new #biologic therapies can be buff.ly/1WaKxbE #Pharma #discovery
Spinal biologists treatment @ goo.gl/eOPx5e . Solutions
#spinesurgery #spinetta #biologic #orthopedics #orthopedicsurgery
#Biosimilars: Impact of #Biologic Product Life Cycle & European Experience on the Regulatory Trajectory in the US bit.ly/1q3mYnC
1
1
Cutting-Edge Approaches to Ensuring #Biologic Drug Quality Focus of Upcoming USP Forum on Bioassays uspgo.to/TOombk #pharmaceutical
1